WWC2-AS2
gene geneOn this page
Also known as FLJ30277
Summary
WWC2-AS2 (WWC2 antisense RNA 2, HGNC:26390) is a long non-coding RNA gene on chromosome 4q35.1.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26390 |
| Approved symbol | WWC2-AS2 |
| Name | WWC2 antisense RNA 2 |
| Location | 4q35.1 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | FLJ30277 |
| Ensembl gene | ENSG00000251359 |
| Ensembl biotype | lncRNA |
| Entrez | 152641 |
| RNAcentral | URS000075BD3B — lncRNA, 2179 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 12 lncRNA
ENST00000578387, ENST00000849454, ENST00000849455, ENST00000849456, ENST00000849457, ENST00000849458, ENST00000849459, ENST00000849460, ENST00000849461, ENST00000849462, ENST00000849463, ENST00000849464
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000578387 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002731697 | 183097017 | 183099199 |
Expression profiles
Bgee: expression breadth ubiquitous, 137 present calls, max score 82.47.
FANTOM5 (CAGE): breadth broad, TPM avg 0.4298 / max 11.4203, expressed in 225 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 55086 | 0.4298 | 225 |
Top tissues by expression
236 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| pancreatic ductal cell | CL:0002079 | 82.47 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.73 | gold quality |
| ileal mucosa | UBERON:0000331 | 67.27 | gold quality |
| upper arm skin | UBERON:0004263 | 66.77 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 65.00 | gold quality |
| tibialis anterior | UBERON:0001385 | 64.70 | silver quality |
| gingival epithelium | UBERON:0001949 | 64.45 | gold quality |
| ventricular zone | UBERON:0003053 | 62.81 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 62.04 | gold quality |
| stromal cell of endometrium | CL:0002255 | 61.77 | gold quality |
| deltoid | UBERON:0001476 | 61.77 | silver quality |
| gingiva | UBERON:0001828 | 61.56 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 61.27 | gold quality |
| bone marrow | UBERON:0002371 | 60.35 | gold quality |
| calcaneal tendon | UBERON:0003701 | 60.20 | gold quality |
| myocardium | UBERON:0002349 | 60.08 | gold quality |
| ganglionic eminence | UBERON:0004023 | 59.60 | gold quality |
| sural nerve | UBERON:0015488 | 58.80 | silver quality |
| nasal cavity epithelium | UBERON:0005384 | 58.35 | gold quality |
| leukocyte | CL:0000738 | 58.19 | silver quality |
| secondary oocyte | CL:0000655 | 57.85 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 57.72 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 57.38 | silver quality |
| cardia of stomach | UBERON:0001162 | 57.25 | gold quality |
| right lobe of liver | UBERON:0001114 | 56.37 | gold quality |
| right coronary artery | UBERON:0001625 | 56.20 | gold quality |
| thoracic aorta | UBERON:0001515 | 56.09 | gold quality |
| mammalian vulva | UBERON:0000997 | 55.97 | gold quality |
| ascending aorta | UBERON:0001496 | 55.75 | gold quality |
| upper leg skin | UBERON:0004262 | 55.63 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.28 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.